Gentell Honey Hydrogel Hydrogel 4oz. Tube. Wound dressing containing hydrogel and honey (100% Le...
FDA Device Recall #Z-1910-2020 — Class II — March 26, 2020
Recall Summary
| Recall Number | Z-1910-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 26, 2020 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Gentell, Inc |
| Location | Bristol, PA |
| Product Type | Devices |
| Quantity | 4,419 |
Product Description
Gentell Honey Hydrogel Hydrogel 4oz. Tube. Wound dressing containing hydrogel and honey (100% Leptospermum honey), Model Number: GEN-11340 - Product Usage: Use Gentell Honey Hydrogel on wounds with little or no exudate, diabetic skin ulcers, venous stasis ulcers, first and second-degree burns, post-surgical incisions, cuts and abrasions.
Reason for Recall
During an FDA audit, it was discovered that the product was not properly registered with FDA.
Distribution Pattern
Worldwide distribution - US Nationwide distributions and the country of South Africa.
Lot / Code Information
Lot Numbers: 1133718 1135318 1101019 1105819 1107119 1110619 1118219 1121119 1122119 1130319
Other Recalls from Gentell, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1907-2020 | Class II | Gentell Honey Hydrogel 2"x2" Saturated Gauze- A... | Mar 26, 2020 |
| Z-1909-2020 | Class II | Gentell Honey Hydrogel 4"x8" Saturated Gauze- A... | Mar 26, 2020 |
| Z-1908-2020 | Class II | Gentell Honey Hydrogel 4"x4" Saturated Gauze- A... | Mar 26, 2020 |
| Z-1624-2020 | Class II | Gentell Hydrogel Ag 4x4, model no. GEN-11420 - ... | Feb 27, 2020 |
| Z-1626-2020 | Class II | Gentell Hydrogel Ag 4oz. Tube, model no. - Prod... | Feb 27, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.